US Patent 11123338 C-met modulator pharmaceutical compositions
Patent 11123338 was granted and assigned to Exelixis Ltd on September, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+103 characters)
Article
Patent abstract
Pharmaceutical compositions and unit dosage forms comprising Compound (I) are disclosed.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jo Ann Wilson0
Khalid Shah0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111233380
Date of Patent
September 21, 2021
0Patent Application Number
201912200
Date Filed
December 20, 2019
0Official Website
Patent Citations Received
Edits on 25 Nov, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11123338 C-met modulator pharmaceutical compositions
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11123338
Date of patent
September 21, 2021
Patent application number
20191220
Date Filed
December 20, 2019
Find more entities like US Patent 11123338 C-met modulator pharmaceutical compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
